Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Nov 22:2024.11.21.24317689.
doi: 10.1101/2024.11.21.24317689.

Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

Affiliations

Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants

Frank Geller et al. medRxiv. .

Update in

  • Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.
    Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Burns A, Rasmussen M, Andersson NW, Quinn L; DBDS Genomic Consortium; Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brøns N, Bybjerg-Grauholm J, Christoffersen LAN, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Grønbæk K, Kaspersen KA, Mikkelsen C, Nielsen CH, Nielsen HS, Nielsen SD, Nissen J, Sequeros CB, Tommerup N, Ullum H; Estonian Biobank Research Team; FinnGen; Spiliopoulos L, Bager P, Hviid A, Sørensen E, Pedersen OB, Lane JM, Lassaunière R, Ollila HM, Ostrowski SR, Feenstra B. Geller F, et al. Nat Genet. 2026 Feb;58(2):299-306. doi: 10.1038/s41588-025-02484-9. Epub 2026 Jan 22. Nat Genet. 2026. PMID: 41571831 Free PMC article.
No abstract available

PubMed Disclaimer

Conflict of interest statement

S.Brunak has ownerships in Intomics A/S, Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S, ALK abello A/S, Eli Lilly and Co and managing board memberships in Proscion A/S and Intomics A/S. C.E. has received unrestricted research grants from Novo Nordisk administered by Aarhus University and Abbott Diagnostics administered by Aarhus University Hospital. C.E. received no personal fees. K.G. received a Janssen Pharma research grant and is on the advisory board of Otsuka Pharma. L.B. currently works for MSD Denmark. All other authors report no competing interests.

Figures

Figure 1:
Figure 1:
Manhattan plot for GWAS of Omicron infection vs. no known infection
Figure 2:
Figure 2:
STRING networks a) STRING network for 13 genes linked to the GWAS lead SNPs. Proteins involved in the Termination of O-glycan biosynthesis pathway are colored in light green, while proteins involved in Glycosphingolipid biosynthesis – lacto and neolacto series are colored in light blue. The two sets of proteins form a connected component with ST6GAL1 and FUT3 acting as the main bridges. The edge width is indicative of the confidence score for each association, with thicker edges denoting higher confidence scores. Physical protein associations are denoted with dotted lines. b) STRING network expanded with 15 additional interactors using a selectivity parameter of 1.0. Four interactors are removed because the corresponding genes were located in genomic loci already covered (FUT5, FUT6, MUC22, MUC3A). Additional proteins that belong to the Termination of O-glycan biosynthesis pathway are shown in dark green and additional proteins that belong to the Glycosphingolipid biosynthesis – lacto and neolacto series pathway are shown in dark blue. The addition of the extra proteins leads to a heavily interconnected network and for this reason we have selected a special coloring scheme to distinguish between the different edges in the network. Solid lines represent associations between the 13 original genes and dashed lines represent associations from the 11 additional genes. Green edges show associations between the genes involved in Termination of O-glycan biosynthesis pathway, blue edges show associations between the genes involved in Glycosphingolipid biosynthesis - lacto and neolacto series pathway and orange lines represent other associations.

References

    1. COVID-19 cases | WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/cases (accession date: 14 November 2024).
    1. Kanai M. et al. A second update on mapping the human genetic architecture of COVID-19. Nat. 2023 6217977 621, E7–E26 (2023). - PMC - PubMed
    1. Markov P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 2023 216 21, 361–379 (2023). - PubMed
    1. Azad M. B., Wade K. H. & Timpson N. J. FUT2 secretor genotype and susceptibility to infections and chronic conditions in the ALSPAC cohort. Wellcome Open Res. 3, (2018). - PMC - PubMed
    1. Varki A. Sialic acids in human health and disease. Trends Mol. Med. 14, 351–360 (2008). - PMC - PubMed

Publication types

LinkOut - more resources